These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 24568466)
1. Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro. Ahmed Ali HA; Di J; Mei W; Zhang YC; Li Y; Du ZW; Zhang GZ Asian Pac J Cancer Prev; 2014; 15(2):611-6. PubMed ID: 24568466 [TBL] [Abstract][Full Text] [Related]
2. Enhanced induction of anti-tumor CTLs in vitro by a lentivirus-transduced dendritic cell vaccine expressing secondary lymphoid tissue chemokine and mucin 1. Wang B; Zhu Y; Zhang JJ; Chen Z; Liang WB; Xu ZK Asian Pac J Cancer Prev; 2011; 12(11):2811-7. PubMed ID: 22393946 [TBL] [Abstract][Full Text] [Related]
3. Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene. Lin L; Wei J; Chen Y; Huang A; Li KK; Zhang W J Cancer Res Clin Oncol; 2014 Feb; 140(2):281-9. PubMed ID: 24322180 [TBL] [Abstract][Full Text] [Related]
4. Dendritic cells transfected with lentiviral vector-encoding hTERT peptide augment antitumor T cell response in vitro. Cui J; Cui L; Liu Q; Sun Q Mol Med Rep; 2012 Jan; 5(1):103-7. PubMed ID: 21971748 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of CTLs induced by DCs loaded with ubiquitinated hepatitis B virus core antigen. Chen JH; Yu YS; Chen XH; Liu HH; Zang GQ; Tang ZH World J Gastroenterol; 2012 Mar; 18(12):1319-27. PubMed ID: 22493545 [TBL] [Abstract][Full Text] [Related]
6. In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12 gene-transfected dendritic cells. Liang W; Wang XF Chin Med J (Engl); 2011 May; 124(9):1357-61. PubMed ID: 21740748 [TBL] [Abstract][Full Text] [Related]
7. Anti-prostate cancer effects of CTL cell induction in vitro by recombinant adenovirus mediated PSMA/4-1BBL dendritic cells: an immunotherapy study. Sui CG; Wu D; Meng FD; Yang MH; Jiang YH Genet Mol Res; 2015 Jun; 14(2):7208-17. PubMed ID: 26125931 [TBL] [Abstract][Full Text] [Related]
8. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT. Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. Specht JM; Wang G; Do MT; Lam JS; Royal RE; Reeves ME; Rosenberg SA; Hwu P J Exp Med; 1997 Oct; 186(8):1213-21. PubMed ID: 9334360 [TBL] [Abstract][Full Text] [Related]
10. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
11. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro. Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500 [TBL] [Abstract][Full Text] [Related]
12. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer Chen J; Guo XZ; Li HY; Zhao JJ; Xu WD World J Gastroenterol; 2017 Feb; 23(5):817-829. PubMed ID: 28223726 [TBL] [Abstract][Full Text] [Related]
14. Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells. Wu L; Zhang H; Jiang Y; Gallo RC; Cheng H Proc Natl Acad Sci U S A; 2018 May; 115(19):E4453-E4462. PubMed ID: 29674449 [TBL] [Abstract][Full Text] [Related]
16. [Silencing of SOCS1 and IL-12 gene cotransferred by adenoviral enhances DC-mediated anti-laryngocarcinoma immunity in vitro]. Li Y; Yuan Y; Wang X Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(19):890-2, 896. PubMed ID: 23285955 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of the antigen-specific cytotoxic T lymphocyte-inducing ability in the PMDC11 leukemic plasmacytoid dendritic cell line via lentiviral vector-mediated transduction of the caTLR4 gene. Iwabuchi M; Narita M; Uchiyama T; Iwaya S; Oiwa E; Nishizawa Y; Hashimoto S; Bonehill A; Kasahara N; Takizawa J; Takahashi M Mol Med Rep; 2015 Aug; 12(2):2443-50. PubMed ID: 25936433 [TBL] [Abstract][Full Text] [Related]
18. [In vitro anti-tumor effect of human dendritic cells vaccine induced by astragalus polysacharin: an experimental study]. Jing XN; Qiu B; Wang JF; Wu YG; Wu JB; Chen DD Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Sep; 34(9):1103-7. PubMed ID: 25335335 [TBL] [Abstract][Full Text] [Related]
19. In vitro antitumor cytotoxic T lymphocyte response induced by dendritic cells transduced with DeltaNp73alpha recombinant adenovirus. Hu Y; He Y; Srivenugopal KS; Fan S; Jiang Y Oncol Rep; 2007 Nov; 18(5):1085-91. PubMed ID: 17914557 [TBL] [Abstract][Full Text] [Related]
20. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]